EBV Subset Identified

Drs. Martin Lerner and Ron Glaser used a specialized testing panel for Epstein-Barr virus (EBV) antibodies to differentiaPloS-ONE-Glaser-199x300te six CFS patients from 20 healthy controls. The CFS patients were treated with valgancyclovir for at least 12 months and all improved based on questionnaire data collected before, during and after treatment. (PLoS ONE; Nov. 14, 2012)

Tags: , November 14, 2012